Skip to content

US · DOCS · MEDICAL - HEALTHCARE INFORMATION SERVICES

Doximity, Inc. (DOCS) intrinsic value and stock valuation

$28.73as of 2026-11-21 · Mkt cap 4.05B

Data updated · price as of 2026-11-21

UndervaluedIC value is 20–50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Doximity, Inc. DCF and intrinsic value

InvestorsCraft values DOCS with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from DOCS’s statements →

Doximity, Inc. Graham Number

Graham Number: $10.95d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Healthcare Information Services San Francisco, CA 94107 doximity.com

How the business is doing

Fiscal 2019–2026, USD

Revenue
$644.9M+25.5% 5y CAGRd
20192026
Net income
$196.1M+31.3% 5y CAGRd
20192026
Free cash flow
$317.5M+32.3% 5y CAGRd
20192026
Total equity
$950.8M+70.1% 5y CAGRd
20192026

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2019–2026, USD
20262025202420232022
Revenue$644.9M$570.4M$475.4M$419.1M$343.6M
Operating income$214.9M$227.8M$163.9M$125.1M$113.5M
Net income$196.1M$223.2M$147.6M$112.8M$154.8M
EPSd$984.9K$1.11M$717.3K$528.6K$810.3K
Operating cash flow$326.5M$273.3M$184.1M$179.6M$126.6M
Capital expenditure-$-8.96M-$-6.53M-$-5.8M-$-6.18M-$-5.7M
Free cash flow$317.5M$266.7M$178.3M$173.4M$120.9M
Total assets$1.12B$1.26B$1.08B$1.14B$991.4M
Total debt$10.2M$12.4M$14.6M$15.6M$1.09M
Net debt-$-208.99M-$-197.22M-$-82.24M-$-142.39M-$-111.72M
Total equity$950.8M$1.08B$901.4M$966.1M$878.6M
Cash and short-term investments$748.6M$915.7M$762.9M$841M$798.1M
Income statement
20262025202420232022
Revenue$644.9M$570.4M$475.4M$419.1M$343.6M
Cost of revenue$70.3M$55.9M$50.7M$53.5M$39.8M
Gross profit$574.5M$514.5M$424.8M$365.6M$303.8M
Research and development expenses$130.7M$93M$82M$80.2M$62.4M
Selling, general and administrative expenses$228.9M$191.4M$171M$160.3M$127.9M
Other expenses$0.00$2.3M$7.94M$0.00$0.00
Operating expenses$359.6M$286.7M$260.9M$240.5M$190.2M
Cost and expenses$429.9M$342.6M$311.5M$293.9M$230M
Interest income$35.7M$35.9M$21.7M$9.29M$2.15M
Interest expense$0.00$0.00$0.00$0.00$0.00
Depreciation and amortization$14.4M$10.7M$10.3M$10.3M$5.04M
Ebitda$264.4M$240.8M$182.1M$143.4M$119.1M
Operating income$214.9M$227.8M$163.9M$125.1M$113.5M
Total other income/expenses, net$35.1M$35.8M$21.3M$8.05M$470K
Income before tax$250M$263.6M$185.2M$133.2M$114M
Income tax expense$54M$40.4M$37.6M$20.3M-$-40.78M
Net income$196.1M$223.2M$147.6M$112.8M$154.8M
Weighted average shares outstanding$187M$186.8M$190.2M$193.2M$163.5M
Weighted average diluted shares outstanding$199.1M$201.2M$205.7M$213.4M$191M
Balance sheet
20262025202420232022
Cash and short-term investments$748.6M$915.7M$762.9M$841M$798.1M
Net receivables$144.8M$128.4M$101.3M$107.1M$81.1M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$944.3M$1.09B$912.9M$975.5M$904.1M
Property, plant and equipment, net$25.2M$22.5M$24.7M$25.1M$9.57M
Goodwill and intangible assets$120.3M$91M$95.3M$99.8M$26.8M
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$179.4M$175.7M$166.4M$161.4M$87.2M
Total assets$1.12B$1.26B$1.08B$1.14B$991.4M
Accounts payable$4.01M$1.36M$2.25M$1.27M$460K
Short-term debt$2.11M$2.21M$2.15M$1.75M$640K
Deferred revenue$106.1M$114.3M$99.1M$105.2M$84.9M
Total current liabilities$155M$156.3M$147.3M$139.5M$111.3M
Long-term debt$8.07M$10.2M$12.4M$13.9M$450K
Deferred revenue, non-current$400K$280K$210K$200K$80K
Total non-current liabilities$17.9M$25.4M$30.7M$31.3M$1.48M
Capital lease obligations$8.07M$12.4M$14.6M$15.6M$1.09M
Total liabilities$172.9M$181.7M$178M$170.8M$112.8M
Common stock$180K$190K$190K$190K$190K
Retained earnings-$-51.06M$186.9M$80M$217.9M$191.1M
Accumulated other comprehensive income (loss)$30K$1.32M-$-2.66M-$-14.08M-$-15.29M
Total equity$950.8M$1.08B$901.4M$966.1M$878.6M
Total investments$529.4M$706.1M$666.1M$683M$685.3M
Total debt$10.2M$12.4M$14.6M$15.6M$1.09M
Net debt-$-208.99M-$-197.22M-$-82.24M-$-142.39M-$-111.72M
Cash flow statement
20262025202420232022
Net income$196.1M$223.2M$147.6M$112.8M$154.8M
Depreciation and amortization$14.4M$10.7M$10.3M$10.3M$5.04M
Stock-based compensation$121.6M$72.4M$51.1M$47.8M$31.4M
Change in working capital-$-45.7M-$-24.1M-$-24.52M-$-21.03M-$-40.33M
Accounts receivable-$-16.88M-$-27.21M$3.99M-$-26.24M-$-31.02M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$4.27M-$-660K$8.33M-$-200K$8.66M
Net cash provided by operating activities$326.5M$273.3M$184.1M$179.6M$126.6M
Investments in property, plant and equipment-$-8.96M-$-6.53M-$-150K-$-6.18M-$-5.7M
Acquisitions, net-$-26.53M$0.00$0.00-$-53.5M$0.00
Net cash used for investing activities$147.2M-$-29.3M$31.2M-$-59.92M-$-640.57M
Common stock issued$13.7M$23.3M$0.00$0.00$553.9M
Common stock repurchased-$-431.65M-$-120.29M-$-280.72M-$-85.32M-$-2.7M
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-464.06M-$-131.14M-$-276.52M-$-74.46M$560.4M
Net change in cash$9.56M$112.8M-$-61.24M$45.2M$46.4M
Cash at end of period$219.2M$209.6M$96.8M$158M$112.8M
Operating cash flow$326.5M$273.3M$184.1M$179.6M$126.6M
Capital expenditure-$-8.96M-$-6.53M-$-5.8M-$-6.18M-$-5.7M
Free cash flow$317.5M$266.7M$178.3M$173.4M$120.9M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Doximity, Inc.

        Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.

        CEO
        Jeffrey A. Tangney
        Employees
        880
        Beta
        1.29

        Explore

        Frequently asked questions

        What is the intrinsic value of Doximity, Inc. (DOCS)?

        Doximity, Inc. (DOCS) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is DOCS undervalued?

        DOCS trades at a price of $28.73 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.